Amirnovin Ramin MD is categorized under Business Services (Unclassified) in Pomona, CA and active since 2010.
Amirnovin Ramin MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact Ramin Amirnovin at the company’s single location by writing to 255 East Bonita Avenue, Pomona, California CA 91767 or by phoning (909) 450-0369. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Amirnovin Ramin MD |
Contact Person: | Ramin Amirnovin |
Address: | 255 East Bonita Avenue, Pomona, California 91767 |
Phone Number: | (909) 450-0369 |
Website Address: | inisurgeons.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Business Services (Unclassified) |
SIC Code: | 7389 |
NAICS Code: | 561499 |
Share This Business: |
Amirnovin Ramin MD was started in 2010 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Ramin Amirnovin for inquiries that concern Amirnovin Ramin MD by calling the company number (909) 450-0369, as your correspondence is most welcome. Additionally, the physical location of the single location of Amirnovin Ramin MD can be found at the coordinates 34.09628,-117.74626 as well as the street address 255 East Bonita Avenue in Pomona, California 91767.
For its online presence, you may visit Amirnovin Ramin MD’s website at inisurgeons.com and engage with its social media outlets through on Twitter and on Facebook.